TTAM Research Institute acquires 23andMe in a $305 million bankruptcy sale, transitioning the DNA testing giant to a ...

This editorial originally ran in fellow CNHI paper The (Sunbury). Individuals have long valued privacy for themselves and their families, while often — knowingly or unknowingly — giving it away. It is ...

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

When it comes to groundbreaking biotech advancements, Eric Faw Intellia is a name you might wanna keep an eye on. This ...

New research from the Perelman School of Medicine at the University of Pennsylvania has challenged the belief that the likelihood of finding undiagnosed genetic conditions decreases with age. “Our ...

CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

A U.S. bankruptcy judge has cleared 23andMe’s $305 million sale to TTAM Research, a nonprofit led by co-founder Anne Wojcicki ...

Genetic testing company 23andMe can proceed with a $305 million sale to the company’s co-founder Anne Wojcicki after a U.S.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 10 Best Value Stocks to Buy According to Billionaires.

The FDA on Wednesday granted accelerated approval to Regeneron ’s bispecific antibody linvoseltamab for the treatment of patients with relapsed or refractory multiple myeloma. The pharma will market ...